Overview

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

Status:
Not yet recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, placebo-controlled, parallel-group study with optional open-label extension.
Phase:
Phase 2
Details
Lead Sponsor:
Tang-Du Hospital